Galantamine for recent ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You had an ischemic stroke (clot-caused) within the last 3 days.
- Your stroke symptoms are moderate (score of 4–25 on a common stroke scale).
- This is your first stroke, or you had no major lasting problems from a previous stroke.
- You are willing to sign a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a specific ginkgo-based medicine (Ginkgo Diterpene Lactone Meglumine) can help people who had an ischemic stroke within the last 48 hours. It looks at whether taking this drug improves recovery compared to standard care.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This study tests whether two herbal medicines (Dengzhan Xixin and Dengzhan Shengmai) can help people recover better after a recent stroke. Researchers will track how these medicines work in your body over time.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This trial studies an herbal treatment given after an ischemic stroke to see if it improves recovery during rehab. It may help people regain more movement and daily function after stroke.
This study uses traditional Chinese medicine (TCM) diagnostic tools to evaluate patients who had an ischemic stroke within the last 10 days. It aims to understand the acute and chronic phases of stroke to help guide future treatments.
Hear when a new Acute Ischemic Stroke AIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.